Geode Capital Management’s Boundless Bio BOLD Stock Holding History

Geode Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Sell	116,736 -10,840	-8%	-$16.7K	﹤0.01%	3795
2026 Q1	$140K	Buy	127,576 +33,478	+36%	+$39.2K	﹤0.01%	4034
2025 Q4	$113K	Sell	94,098 -8,170	-8%	-$10.2K	﹤0.01%	4068
2025 Q3	$126K	Buy	102,268 +43,365	+74%	+$50.1K	﹤0.01%	4070
2025 Q2	$59.5K	Sell	58,903 -188,240	-76%	-$250K	﹤0.01%	4179
2025 Q1	$373K	Buy	247,143 +11,284	+5%	+$23.4K	﹤0.01%	3648
2024 Q4	$684K	Buy	235,859 +119,232	+102%	+$347K	﹤0.01%	3502
2024 Q3	$405K	Buy	116,627 +5,993	+5%	+$21.7K	﹤0.01%	3677
2024 Q2	$428K	Buy	+110,634	New	+$1.06M	﹤0.01%	3623

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management's BOLD Position: Q2 2026 in Review

Geode Capital Management reduced its Boundless Bio (BOLD) stake by 8.5% in Q2 2026, selling an estimated $16.7K and leaving 116,736 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #3795.

Geode Capital Management first reported a position in BOLD in Q2 2024 and has held it in 9 quarters since. The position peaked at $684K in Q4 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Geode Capital Management held 116,736 shares of Boundless Bio worth $292K as of Q2 2026.
Geode Capital Management sold 10,840 Boundless Bio shares in Q2 2026, an estimated $16.7K.
Boundless Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3795 holding.
Geode Capital Management first reported a position in Boundless Bio in Q2 2024 and has held it in 9 quarters since.
Geode Capital Management's Boundless Bio position peaked at $684K in Q4 2024.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.